Omalizumab for the Treatment of Food Allergy in Patients With Elevated Total IgE Levels
Clinical trial NCT06934200 · RECRUITING
Trial details
- NCT number
- NCT06934200
- Sponsor
- Johns Hopkins University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-19
- Primary completion
- 2027-04-15
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.